Back
Shockwave Medical Quote, Financials, Valuation and Earnings
Sponsored
SWAV
Sponsored
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to See
Buy
58
SWAV
Shockwave Medical
Last Price:
325.46
Seasonality Move:
42.38%
7 Day Trial
ALL ACCESS PASS
$
7
NEW: AI Breakthrough to Send Economy Skyrocketing by $200 Trillion?
And with the one move I detail here, you can secure a share of this 10,000% boom.Shockwave Medical Price Quote
$325.46
-0.17 (0.97%)
(Updated: March 29, 2024 at 6:53 AM ET)
Shockwave Medical Key Stats
Buy
58
Shockwave Medical (SWAV)
is a Buy
Day range:
$322.61 - $331.58
52-week range:
$157.00 - $331.58
Dividend yield:
0%
P/E ratio:
84.58
P/S ratio:
17.02
P/B ratio:
18.21%
Volume:
808K
Avg. volume:
695K
1-year change:
51.32%
Market cap:
$12.2B
Revenue:
$730.2M
EPS:
$3.87
How Much Does Shockwave Medical Make?
-
How Much Are Shockwave Medical's Sales Annually?
SWAV Revenues are $730.2M -
How Much Profit Does Shockwave Medical's Make A Year?
SWAV net income is $147.3M
Is Shockwave Medical Growing As A Company?
-
What Is Shockwave Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.41% -
What Is Shockwave Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.69%
Shockwave Medical Stock Price Performance
-
Did Shockwave Medical Stock Go Up Last Month?
Shockwave Medical share price went up by 24.03% last month -
Did SWAV's Share Price Rise Over The Last Year?
SWAV share price rose by 51.32% over the past 1 year
What Is Shockwave Medical 52-Week High & Low?
-
What Is Shockwave Medical’s 52-Week High Share Price?
Shockwave Medical has traded as high as $331.58 over the past 52 weeks -
What Is Shockwave Medical’s 52-Week Low Share Price?
Shockwave Medical has traded as low as $157.00 over the past 52 weeks
Shockwave Medical Price To Free Cash Flow
-
Is Shockwave Medical Stock Overvalued?
Shockwave Medical is trading at a price to free cash flow ratio of 75.12 -
Is Shockwave Medical Stock Undervalued?
Shockwave Medical EV to Free Cash Flow ratio is 72.04 -
What Is Shockwave Medical’s Price Earnings Growth Ratio?
SWAV PEG ratio is 0.00 -
Is Shockwave Medical Trading At A Premium To Earnings?
Shockwave Medical EV to EBIT ratio is 65.78
Is It Risky To Buy Shockwave Medical?
-
How Much Debt Does Shockwave Medical Have?
Total long term debt quarterly is $731.9M -
How Much Cash Does Shockwave Medical Have?
Cash and short term investments quarterly total is $990.6M -
What Is Shockwave Medical’s Book Value Per Share?
Book value per share is 18.08
Is Shockwave Medical Cash Flow Positive?
-
What Is SWAV Cash Flow From Operations?
Cash flow from operations (TTM) is $196.1M -
What Is Shockwave Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $600.4M -
What Is Shockwave Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$625.7M
Shockwave Medical Return On Invested Capital
-
Is Management Doing A Good Job?
SWAV return on invested capital is 16.06% -
What Is Shockwave Medical Return On Assets?
ROA measures how assets are converting to revenues and is 14.01% -
What Is SWAV Return On Equity?
ROE is a measure of profitability and is 24.8%
Shockwave Medical Earnings Date & Stock Price
-
What Is Shockwave Medical's Stock Price Today?
A single share of SWAV can be purchased today for 325.63 -
What Is Shockwave Medical’s Stock Symbol?
Shockwave Medical trades on the nasdaq under the ticker symbol: SWAV -
When Is Shockwave Medical’s Next Earnings Date?
The next quarterly earnings date for Shockwave Medical is scheduled on May 6, 2024 -
When Is SWAV's next ex-dividend date?
Shockwave Medical's next ex-dividend date is March 29, 2024 -
How To Buy Shockwave Medical Stock?
You can buy Shockwave Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Shockwave Medical Competitors
-
Who Are Shockwave Medical's Competitors?
Below is a list of companies who compete with Shockwave Medical or are related in some way:
Shockwave Medical Dividend Yield
Data Unavailable
Shockwave Medical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -68.73% | 36.68% |
Revenue: | 40.93% | 1.77% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 1 |
Price Target: | 266.00 |
Downside from Last Price: | -18.31% |